Bayer

Midol Supplements Peace Out PMS

F
N+ Score54
Sleep & RecoveryServing: 1 Capsule(s)Type: Botanical

Midol Supplements Peace Out PMS is a botanical supplement containing three active ingredients, with full label transparency. The formula includes Ginger powder at 290mg, Chasteberry Fruit Extract at 20mg, and Valerian root extract at 10mg. While these botanicals are commonly used for various purposes, none of the ingredients in this formulation are present at clinically studied dosages, which may limit their potential efficacy based on current research. The product received an N+ Score of 54, earning an 'F' grade, reflecting a below-average assessment for its ingredient adequacy and formula completeness. This product may appeal to individuals interested in a simple botanical blend, but the absence of clinically dosed ingredients suggests a need for further consideration regarding its overall effectiveness.

About This Product

Midol Supplements Peace Out PMS by Bayer is a sleep & recovery supplement containing 3 active ingredients. It has earned an N+ Score of 54/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity83/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Valerian root extract10.000 mgN/A
Ginger, Powder290.000 mgN/A
Chasteberry Fruit Extract20.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.